Actuate Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | -85.4% | +211.1% | +50.6% | |
| – | -85.4% | +207.4% | +48.2% | |
| – | -85.5% | +192.1% | +52.3% | |
| – | -85.5% | +192.1% | +52.3% | |
| – | +1,716.1% | -91.0% | -33.7% | |
| – | +59.3% | +27.2% | -35.2% | |
| – | +60.6% | -43.9% | -20.7% | |
| – | -771.7% | – | +7,505.6% | |
| – | – | – | – | |
| – | +0.0% | +29.8% | +7.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.